


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-9.99%
+4.23%
+18.65%
-15.20%
+4.29%
ALVO
Alvotech
$5.42
Strengths

Upgraded on attractively valued
Risk Analysis

Earnings are forecast to decrease
ALVO Price Performance
$5.13 (+5.65%)
$5.03 (+7.75%)
$8.32 (-34.86%)
$12.99 (-58.28%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease
Analysts perspectives on the stock desirability, trend direction and growth potential
ALVO has Medium risk level
Risks Indicators

Price under $5

Low volume

High volatilty

Average key support and resistance price levels
What is ALVO current stock price?
What are ALVO stock strengths?
What is ALVO Risk Level?
What is ALVO market cap and volume?
What is ALVO current Stock IQ?
Should I buy ALVO stock right now?
Is ALVO a Strong Buy right now?
What does a 'Strong Buy' rating mean for ALVO?
What does a 'Strong Sell' rating mean for ALVO?
What factors influence ALVO's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-9.99%
+4.23%
+18.65%
-15.20%
+4.29%
ALVO
Alvotech
Current Price
$5.42
Stock Insights
Strengths

Upgraded on attractively valued
Risk Analysis

Earnings are forecast to decrease
Recently Viewed
ALVO
Alvotech
5.42
+2.46%
ARCT
Arcturus Therapeutics
7.57
+2.71%
GBTG
Global Business Travel
7.00
+2.19%
HOOD
Robinhood Markets In
101.24
-2.09%
PNR
Pentair
105.91
+0.70%

ALVO Price Performance
$5.13 (+5.65%)
$5.03 (+7.75%)
$8.32 (-34.86%)
$12.99 (-58.28%)
ALVO Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease
Analysts perspectives on the stock desirability, trend direction and growth potential
ALVO has Medium risk level
Risks Indicators

Price under $5

Low volume

High volatilty

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Nov 19, 2025
Reiterate
Buy
UBS
ALVO Stock IQ
ALVO Latest Analysis
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg. REYKJAVIK Iceland Jan. 29 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide today announced that it has reached a licensing and settlement agreement with Regeneron and Bayer resolving all remaining patent disputes worldwide related to Alvotechs biosimilar to Eylea® 2mg (aflibercept 40
Today
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ALVO Stock trends
ALVO Stock performance
ALVO Stock analysis
ALVO investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.